Equels Thomas K.
AIM ImmunoTech Inc. · CEO & President
Equels Thomas K. is listed in filings as CEO & President at AIM ImmunoTech Inc.. This profile follows SEC Form 4 activity through Mar 16, 2026, including purchase activity. Recent filings connect the profile to AIM ImmunoTech Inc. (AIM). The current snapshot covers public activity from Aug 12, 2024 to Mar 16, 2026. Reported amounts are shown as $50.0K to $824. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $896103 shares | BuyJun 12, 2025 | $8.70 | $0.245 | |
| $50k2M shares | BuyApr 11, 2025 | $0.0254 | $0.245 | |
| $2.6k41k shares | BuyApr 4, 2025 | $0.063 | $0.245 | |
| $6.7k50k shares | BuyMar 5, 2025 | $0.1346 | $0.245 | |
| $10k83.3k shares | BuyMar 4, 2025 | $0.12 | $0.245 | |
| $5.1k44k shares | BuyMar 4, 2025 | $0.115 | $0.245 | |
| $4.7k22.7k shares | BuyDec 18, 2024 | $0.206 | $0.245 | |
| $4.2k20k shares | BuyNov 21, 2024 | $0.212 | $0.245 | |
| $17k85k shares | BuyNov 20, 2024 | $0.199 | $0.245 | |
| $11k60.1k shares | BuyNov 20, 2024 | $0.183 | $0.245 | |
| $1.5k5k shares | BuySep 16, 2024 | $0.303 | $0.245 | |
| $6.2k20k shares | BuySep 13, 2024 | $0.308 | $0.245 |